Interestingly, parkin mRNA and protein expression are significantly decreased in breast cancer, but no significant changes in cyclin D1 and cyclin E levels are observed, while cyclin-dependent kinase 6 (CDK6) expression level is significantly increased. The gene discussed is PRKN; the disease is breast carcinoma.